Abstract
Interstitial brachytherapy is one of several curative therapeutic options for the treatment of localized prostate cancer. In this review, we summarize all available randomized data to support the optimal use of prostate brachytherapy. Evidence from completed randomized controlled trials is the focus of this review with a presentation also of important ongoing trials. Gaps in knowledge are identified where future investigation may be fruitful with intent to inspire well-designed prospective studies with standardized treatment that focuses on improving oncological outcomes, reducing morbidity, or maintaining quality of life.
Author supplied keywords
Cite
CITATION STYLE
Dess, R. T., Soni, P. D., Jackson, W. C., Berlin, A., Cox, B. W., Jolly, S., … Spratt, D. E. (2019, September 1). The current state of randomized clinical trial evidence for prostate brachytherapy. Urologic Oncology: Seminars and Original Investigations. Elsevier Inc. https://doi.org/10.1016/j.urolonc.2019.04.009
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.